α-Synuclein pathology in LRRK2 Parkinson disease

IF 28.2 1区医学 Q1 CLINICAL NEUROLOGY

Nature Reviews Neurology Pub Date : 2025-06-18 DOI:10.1038/s41582-025-01113-7

Ian Fyfe

引用次数: 0

Abstract

Absence of Lewy body pathology in the form of Parkinson disease caused by mutations in the LRRK2 gene does not equate to a lack of α-synuclein pathology, two new studies have shown.

查看原文本刊更多论文

α-突触核蛋白与LRRK2帕金森病的病理关系

两项新的研究表明，由LRRK2基因突变引起的帕金森病形式的路易体病理缺失并不等同于缺乏α-突触核蛋白病理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Neurology 医学-临床神经学

CiteScore

29.90

自引率

0.80%

发文量

138

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Neurology aims to be the premier source of reviews and commentaries for the scientific and clinical communities we serve. We want to provide an unparalleled service to authors, referees, and readers, and we work hard to maximize the usefulness and impact of each article. The journal publishes Research Highlights, Comments, News & Views, Reviews, Consensus Statements, and Perspectives relevant to researchers and clinicians working in the field of neurology. Our broad scope ensures that the work we publish reaches the widest possible audience. Our articles are authoritative, accessible, and enhanced with clearly understandable figures, tables, and other display items. This page gives more detail about the aims and scope of the journal.